Adirondack Research & Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,000
Closed -$6K 113
2017
Q3
$6K Sell
1,000
-57,861
-98% -$390K ﹤0.01% 107
2017
Q2
$454K Sell
58,861
-98,430
-63% -$832K 0.18% 85
2017
Q1
$1.42M Sell
157,291
-81,100
-34% -$845K 0.51% 60
2016
Q4
$2.58M Hold
238,391
0.88% 49
2016
Q3
$3.9M Sell
238,391
-203,668
-46% -$2.87M 1.41% 33
2016
Q2
$4.21M Buy
442,059
+3,685
+0.8% +$40.1K 1.58% 27
2016
Q1
$6.16M Sell
438,374
-166,279
-27% -$1.72M 2.23% 9
2015
Q4
$6.57M Sell
604,653
-67,651
-10% -$611K 2.38% 5
2015
Q3
$4.58M Hold
672,304
1.75% 17
2015
Q2
$6.14M Sell
672,304
-118,000
-15% -$894K 2.25% 6
2015
Q1
$5.33M Sell
790,304
-18,669
-2% -$75.1K 2.07% 14
2014
Q4
$2.73M Buy
808,973
+33,311
+4% +$107K 1.02% 45
2014
Q3
$2.6M Buy
775,662
+102,681
+15% +$321K 0.96% 52
2014
Q2
$2.8M Buy
672,981
+523,581
+350% +$2.77M 0.95% 54
2014
Q1
$1.19M Buy
+149,400
New +$1.11M 0.45% 72

Other funds holding NPTN

Adirondack Research & Management's NPTN Position: Q4 2017 in Review

Adirondack Research & Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2017, closing a stake of 1,000 shares — an estimated $6K sold.

Adirondack Research & Management first reported a position in NPTN in Q1 2014 and held it in 15 quarters. The position peaked at $6.57M in Q4 2015. 92 funds tracked by Wall St. Rank hold NPTN as of Q4 2017.

  • Adirondack Research & Management reported no remaining NEOPHOTONICS CORP position as of Q4 2017 after selling out during the quarter.
  • Adirondack Research & Management sold 1,000 NEOPHOTONICS CORP shares in Q4 2017, an estimated $6K.
  • Adirondack Research & Management first reported a position in NEOPHOTONICS CORP in Q1 2014 and held it in 15 quarters.
  • Adirondack Research & Management's NEOPHOTONICS CORP position peaked at $6.57M in Q4 2015.
  • 92 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2017.

Based on Adirondack Research & Management's 13F filing for Q4 2017, filed 12 Feb 2018.